Inventor · disambiguated record
Michel Rathbone
Also filed as: RATHBONE MICHEL · RATHBONE MICHEL P
8 granted patents·10 pending applications·80 citations·filing 1995–2018
87Inventor score
Files withAVENTIS PHARMA INC10LIBRAMEN NATURALS INC2NEUROLOGICAL TECHNOLOGIES INC1RATHBONE MICHEL P1SPECTRUM PHARMACEUTICALS INC1
Top patents by PatentIndex Score
18 records- 0187US7179821B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Feb 20, 2007·7 cites·2 claims
- 0285US7230015B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Jun 12, 2007·5 cites·2 claims
- 0384US6967210B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2002·Granted Nov 22, 2005·14 cites·24 claims
- 0483US7534803B2Method of treating demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted May 19, 2009·4 cites·2 claims
- 0571US5801184ACarbon monoxide dependent guanylyl cyclase modifiers and methods of useFiled 1995·Granted Sep 1, 1998·34 cites·16 claims
- 0668US2009209594A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2009·Application pending·0 cites
- 0768US2009209595A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2009·Application pending·0 cites
- 0868US2009281147A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2009·Application pending·0 cites
- 0968US2009270458A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2009·Application pending·0 cites
- 1063US6350752B1Carbon monoxide dependent guanylyl cyclase modifiers and methods of useFiled 1997·Granted Feb 26, 2002·16 cites·1 claims
- 1158US2004157888A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 1258US2004157889A1Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 1354US2006063788A1Carbon monoxide dependent guanylyl cyclase modifiers and methods of useSPECTRUM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1451US2011014694A1Use of enteric gliaNEUROLOGICAL TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 1548US2002165242A1Carbon monoxide dependent guanylyl cyclase modifiers and methods of useFiled 2002·Application pending·0 cites
- 1647US2006147425A1Use of enteric glia to promote functional nerve connectionsRATHBONE MICHEL P·Filed 2003·Application pending·0 cites
- 1745US10520491B2Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptorsLIBRAMEN NATURALS INC·Filed 2018·Granted Dec 31, 2019·0 cites·12 claims
- 1842US10012641B2G-protein-coupled-receptor-22-transformed cell lines and methods of use thereof to identify binding compoundsLIBRAMEN NATURALS INC·Filed 2016·Granted Jul 3, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Michel Rathbone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →